|

Protecting Human Subjects in Research: Are Current Safeguards Adequate?

Protecting Human Subjects in Research: Are Current Safeguards Adequate? AHRP Testimony submitted to Congressional Committee April 23, 2002 Vera Hassner Sharav, President, and John H. Noble, Jr., Ph.D., steering committee member, The Alliance for Human Research Protection (AHRP), before the Subcommittee on Public Health, Committee on Health, Education, Labor, &…

Ritalin: Chromosome Abnormalities Occured in All 12 Children / High school prescription drug abuse

Ritalin: Chromosome Abnormalities Occured in All 12 Children / High school prescription drug abuse Fri, 11 Mar 2005 Parents and public health policy makers have cause for concern about the finding of a study conducted at the University of Texas, MD Anderson Cancer Center. WebMD reports that all 12 children…

Infomail Archive, 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…

Dr. David Healy Addresses Credibility Crisis-at Columbia University Oct. 20

Additional information as of late Wed Oct 19: Although I was assured that attendance for a presentation by Dr. David Healy (at Columbia University School of Public Health on Oct. 20 at 12:30) would be open to the public, a problem seems to have emerged after an AHRP Infomail about…

Researcher Who Challenged ADHD industry cleared of misconduct charges

Researcher Who Challenged ADHD industry cleared of misconduct charges Sun, 16 Oct 2005 If you thought that academia could not prey to McCarthyite bullying tactics–or could not possibly fall prey to anything like the Salem witch hunts—think again. Dr. Gretchen LeFever, a clinical psychologist and associate professor in the department…

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT Sun, 14 Mar 2004 Former Director of the National Institutes of Health, Harold Varmus, MD, appeared before a blue ribbon panel convened by his former agency, ostensibly to shed light on conflict of interest at…

Linguistic Tinkering with Regulatory Terminology Increases Risk of Harm for Children

Linguistic Tinkering with Regulatory Terminology Increases Risk of Harm for Children: "minimal risk" "minor increment of minimal risk" and "disorder or condition" January 28, 2001 A cornerstone of the Declaration of Helsinki (adopted by the World Medical Association in 1964, and reaffirmed on Oct. 2000) is the distinction between research…

Instead of a War against Drugs, Children Riddled with Psych Drugs

Instead of a War against Drugs, Children Riddled with Psych Drugs Tue, 14 Jan 2003 In his 1994 book, The War on Children, psychiatrist, Dr. Peter Breggin exposed the practice of prescribing psychiatric drugs as a method for controlling children’s behavior. Dr. Breggin was reviled by the psychiatric establishment, even…

Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America – Whitaker

Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America by Robert Whitaker, Ethical Human Psychology and Psychiatry, Volume 7, Number I , Spring 2005 Mon, 29 Aug 2005 Some uncritical promoters of psychiatry and its current biological treatment paradigm have declared that the introduction…